treatment

ESHRE Issues 2022 Revision of Endometriosis Guideline

The European Society of Human Reproduction and Embryology has updated its guidelines on the diagnosis and treatment of endometriosis in adolescent and adult women.

The 2022 guideline is a full revision of the previous “Guideline on the Management of Women with Endometriosis” issued in 2014. The new guideline no longer recommends laparoscopy as the criterion standard for the diagnosis of endometriosis. Laparoscopy is now only recommended for patients with negative imaging results or when empiric treatment has proven unsuccessful or is inappropriate.

Regarding treatment for endometriosis pain, the 2022 guideline recommends the use of gonadotropin-releasing hormone (GnRH) antagonists as an additional second-line treatment option. However, danazol and antiprogestogens, antiadhesion agents, laparoscopic uterosacral nerve ablation, and presacral neurectomy are no longer recommended for treating such pain. Moreover, preoperative hormone treatment to improve the immediate outcome of surgery for endometriosis pain is not recommended.

Regarding treatment for endometriosis-related infertility, the Endometriosis Fertility Index was added as a treatment step that can support decision-making regarding the best option for achieving pregnancy after endometriosis surgery. The revised guideline also strongly recommends that women who wish to become pregnant should not receive postoperative hormone suppression solely to enhance future pregnancy rates. In addition, the ultralong protocol, or the extended administration of a GnRH agonist, is no longer recommended before assisted reproductive technology treatment because of its unclear benefit in improving the live birth rate in infertile women with endometriosis.

Compared with the 2014 guideline, the new guideline includes additional information on pregnancy and fertility preservation and more extensive information on menopause and cancer in women with endometriosis.

Endometriosis in adolescents, which was not included in the 2014 guideline, is covered extensively in the new guideline, which devotes a separate chapter to endometriosis recurrence to highlight its importance and challenges.

—Ellen Kurek

Reference:

ESHRE Endometriosis Guideline Development Group. Endometriosis: Guideline of the European Society of Human Reproduction and Embryology. Published online February 2, 2022. https://www.eshre.eu/Guidelines-and-Legal/Guidelines/Endometriosis-guideline

Current Consultant Issue

Previous Issues

Early View

Research Summaries

Conference Coverage

Fatigue, Headache Are Primary Symptoms of Long COVID Among Patients 21 Years of Age or Younger

10/07/2024

Anthony Calabro, MA

Researchers aimed to describe the most common symptoms of long COVID and the progression of symptoms over time. They presented their findings at IDWeek 2023 in Boston, Massachusetts.

10/07/2024

Depression Care360

Depression Rates Saw Hike in Last 4 Years, During Pandemic Especially

10/02/2024

Rates of clinically diagnosed depression and anxiety without depression increased between 2017 and 2021, especially during the COVID-19 pandemic, according to recent cohort study results published in JAMA...

10/02/2024

Research Summary

Research Summary

Can Mindfulness-Based Stress Reduction Improve Quality of Life for Patients With HIV?

09/30/2024

Miranda Manier, BA

Researchers conducted a randomized trial to evaluate the impact of mindfulness-based stress reduction on depression and quality of life in older adults living with HIV and cognitive impairment.

09/30/2024

Conference Coverage

Long-Term Follow-Up Shows Continued Efficacy of Iomab B-Led Allogeneic Hematopoietic Cell Transplantation in Older Patients With Active, R/R AML

09/30/2024

Anthony Calabro, MA

In a long-term follow-up to SIERRA, a multicenter, randomized, controlled phase 3 study, researchers found that patients 55 years of age or older with active relapsed or refractory acute myeloid leukemia...

09/30/2024

Research Summary

Pembrolizumab Plus Chemotherapy Did Not Improve Disease-Free Survival in Patients With High-Risk Endometrial Cancer

09/30/2024

Anthony Calabro, MA

Although the immunotherapy plus chemotherapy did not improve disease-free survival (DFS) in newly diagnosed, high-risk patients with endometrial cancer, the combination therapy did improve DFS for patients...

09/30/2024

Trending Articles

Pop Quiz

Treatment Strategies For Patients With PsA Who Do Not Respond To TNFi

09/10/2024

In an interview with Consultant360, study author Ying-Ying Leung, MD, MBChB said this about the treatment strategies for patients with PsA who do not respond to tumor necrosis factor inhibitors:...

09/10/2024

Pop Quiz

Onset of Rheumatoid Arthritis

09/08/2024

Rheumatoid arthritis (RA) can begin at any age, but the likelihood increases with age. What is the approximate age when the onset of RA is most likely?

09/08/2024